283 related articles for article (PubMed ID: 19276186)
1. A negative feedback regulatory loop associates the tyrosine kinase receptor ERBB2 and the transcription factor GATA4 in breast cancer cells.
Hua G; Zhu B; Rosa F; Deblon N; Adélaïde J; Kahn-Perlès B; Birnbaum D; Imbert J
Mol Cancer Res; 2009 Mar; 7(3):402-14. PubMed ID: 19276186
[TBL] [Abstract][Full Text] [Related]
2. ERBB2-mediated transcriptional up-regulation of the alpha5beta1 integrin fibronectin receptor promotes tumor cell survival under adverse conditions.
Spangenberg C; Lausch EU; Trost TM; Prawitt D; May A; Keppler R; Fees SA; Reutzel D; Bell C; Schmitt S; Schiffer IB; Weber A; Brenner W; Hermes M; Sahin U; Türeci O; Koelbl H; Hengstler JG; Zabel BU
Cancer Res; 2006 Apr; 66(7):3715-25. PubMed ID: 16585198
[TBL] [Abstract][Full Text] [Related]
3. Cofactor competition between the ligand-bound oestrogen receptor and an intron 1 enhancer leads to oestrogen repression of ERBB2 expression in breast cancer.
Newman SP; Bates NP; Vernimmen D; Parker MG; Hurst HC
Oncogene; 2000 Jan; 19(4):490-7. PubMed ID: 10698518
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth.
Zhao YH; Zhou M; Liu H; Ding Y; Khong HT; Yu D; Fodstad O; Tan M
Oncogene; 2009 Oct; 28(42):3689-701. PubMed ID: 19668225
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling detects gene amplification and differentiates tumor types in breast cancer.
Dressman MA; Baras A; Malinowski R; Alvis LB; Kwon I; Walz TM; Polymeropoulos MH
Cancer Res; 2003 May; 63(9):2194-9. PubMed ID: 12727839
[TBL] [Abstract][Full Text] [Related]
6. Macrophage inhibitory cytokine-1 activates AKT and ERK-1/2 via the transactivation of ErbB2 in human breast and gastric cancer cells.
Kim KK; Lee JJ; Yang Y; You KH; Lee JH
Carcinogenesis; 2008 Apr; 29(4):704-12. PubMed ID: 18258606
[TBL] [Abstract][Full Text] [Related]
7. Metastatic lymph node 64 (MLN64), a gene overexpressed in breast cancers, is regulated by Sp/KLF transcription factors.
Alpy F; Boulay A; Moog-Lutz C; Andarawewa KL; Degot S; Stoll I; Rio MC; Tomasetto C
Oncogene; 2003 Jun; 22(24):3770-80. PubMed ID: 12802284
[TBL] [Abstract][Full Text] [Related]
8. Identification of HTF (HER2 transcription factor) as an AP-2 (activator protein-2) transcription factor and contribution of the HTF binding site to ERBB2 gene overexpression.
Vernimmen D; Begon D; Salvador C; Gofflot S; Grooteclaes M; Winkler R
Biochem J; 2003 Feb; 370(Pt 1):323-9. PubMed ID: 12418962
[TBL] [Abstract][Full Text] [Related]
9. Regulation of heparanase gene expression by estrogen in breast cancer.
Elkin M; Cohen I; Zcharia E; Orgel A; Guatta-Rangini Z; Peretz T; Vlodavsky I; Kleinman HK
Cancer Res; 2003 Dec; 63(24):8821-6. PubMed ID: 14695198
[TBL] [Abstract][Full Text] [Related]
10. A novel mechanism for integrin-mediated ras activation in breast carcinoma cells: the alpha6beta4 integrin regulates ErbB2 translation and transactivates epidermal growth factor receptor/ErbB2 signaling.
Yoon SO; Shin S; Lipscomb EA
Cancer Res; 2006 Mar; 66(5):2732-9. PubMed ID: 16510594
[TBL] [Abstract][Full Text] [Related]
11. Copine-III interacts with ErbB2 and promotes tumor cell migration.
Heinrich C; Keller C; Boulay A; Vecchi M; Bianchi M; Sack R; Lienhard S; Duss S; Hofsteenge J; Hynes NE
Oncogene; 2010 Mar; 29(11):1598-610. PubMed ID: 20010870
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide identification of direct target genes implicates estrogen-related receptor alpha as a determinant of breast cancer heterogeneity.
Deblois G; Hall JA; Perry MC; Laganière J; Ghahremani M; Park M; Hallett M; Giguère V
Cancer Res; 2009 Aug; 69(15):6149-57. PubMed ID: 19622763
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia down-regulates CCAAT/enhancer binding protein-alpha expression in breast cancer cells.
Seifeddine R; Dreiem A; Blanc E; Fulchignoni-Lataud MC; Le Frère Belda MA; Lecuru F; Mayi TH; Mazure N; Favaudon V; Massaad C; Barouki R; Massaad-Massade L
Cancer Res; 2008 Apr; 68(7):2158-65. PubMed ID: 18381421
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor controls EGFR and ERBB2 gene expression at different levels in prostate cancer cell lines.
Pignon JC; Koopmansch B; Nolens G; Delacroix L; Waltregny D; Winkler R
Cancer Res; 2009 Apr; 69(7):2941-9. PubMed ID: 19318561
[TBL] [Abstract][Full Text] [Related]
15. The proximal Gata4 promoter directs reporter gene expression to sertoli cells during mouse gonadal development.
Mazaud Guittot S; Tétu A; Legault E; Pilon N; Silversides DW; Viger RS
Biol Reprod; 2007 Jan; 76(1):85-95. PubMed ID: 17021344
[TBL] [Abstract][Full Text] [Related]
16. Retinoic acid receptor gamma activates receptor tyrosine kinase Tie1 gene transcription through transcription factor GATA4 in F9 stem cells.
Su D; Gudas LJ
Exp Hematol; 2008 May; 36(5):624-41. PubMed ID: 18439490
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of elafin in normal and tumor-derived mammary epithelial cells is mediated by CCAAT/enhancer binding protein beta.
Yokota T; Bui T; Liu Y; Yi M; Hunt KK; Keyomarsi K
Cancer Res; 2007 Dec; 67(23):11272-83. PubMed ID: 18056453
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional control of the ERBB2 amplicon by ERRalpha and PGC-1beta promotes mammary gland tumorigenesis.
Deblois G; Chahrour G; Perry MC; Sylvain-Drolet G; Muller WJ; Giguère V
Cancer Res; 2010 Dec; 70(24):10277-87. PubMed ID: 20961995
[TBL] [Abstract][Full Text] [Related]
19. A genomic explanation connecting "Mediterranean diet", olive oil and cancer: oleic acid, the main monounsaturated fatty acid of olive oil, induces formation of inhibitory "PEA3 transcription factor-PEA3 DNA binding site" complexes at the Her-2/neu (erbB-2) oncogene promoter in breast, ovarian and stomach cancer cells.
Menendez JA; Papadimitropoulou A; Vellon L; Lupu R
Eur J Cancer; 2006 Oct; 42(15):2425-32. PubMed ID: 16406575
[TBL] [Abstract][Full Text] [Related]
20. The β2-adrenergic receptor and Her2 comprise a positive feedback loop in human breast cancer cells.
Shi M; Liu D; Duan H; Qian L; Wang L; Niu L; Zhang H; Yong Z; Gong Z; Song L; Yu M; Hu M; Xia Q; Shen B; Guo N
Breast Cancer Res Treat; 2011 Jan; 125(2):351-62. PubMed ID: 20237834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
